Acute coronary syndrome is a significant cause of death and illness worldwide. Modern therapies can decrease mortality rates, and ongoing research explores new ways to manage the condition. Ivabradine is a drug that lowers heart rate and had shown potential in improving cardiac function and reducing mortality rates in ACS patients.